91Ö±²¥

Alzheimer’s disease

TA111 Alzheimer’s disease – donepezil, rivastigmine, galantamine and memantine

Age-related macular degeneration

TA155 Age-related macular degeneration – ranibizumab and pegaptanib

Ankylosing spondylitis

TA143 Ankylosing spondylitis – adalimumab, etanercept and infliximab

Breast cancer

ID20 Breast cancer – lapatinib

TA496 Breast cancer – ribociclib

Colorectal cancer

TA176 Colorectal cancer – cetuximab

Crohn's disease

TA187 Crohn's disease – adalimumab and infliximab

Diabetes

TA288 Diabetes – dapagliflozin

TA203 Diabetes – liraglutide

Lung Cancer

TA162 Lung cancer – erlotinib

Lupus

ID416 Lupus – belimumab

Macular oedema

TA274 Macular oedema – bevacizumab

Myelodysplastic syndromes

TA128 Myelodysplastic syndromes – azacitidine

Osteoporosis

TA160 / TA161 Osteoporosis – alendronate, etidronate, risedronate, raloxifene, teriparatide and strontium ranelate

Prostate cancer

ID590 Prostate cancer – degarelix

Renal cell carcinoma

TA178 Renal cell carcinoma – bevacizumab, sorafenib, sunitinib and temsirolimus

Rheumatoid arthritis

TA130 Rheumatoid arthritis – adalimumab, etanercept and infliximab

Rheumatoid arthritis – adalimumab, etanercept and infliximab (sequential use)

ID537 Rheumatoid arthritis – adalimumab, etanercept, inflizimab, certolizumab pegol, golimumab, abatacept and tocilizumab

TA247 Rheumatoid arthritis – tocilizumab